Clinical features and molecular landscape of cuproptosis signature‐related molecular subtype in gastric cancer

Wei Chong(First Hospital of China Medical University), Leping Li(Shandong University)

iMeta

April 5, 2024

10.1002/imt2.190

Cited by 29

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

A novel 3’tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer

|Cell Death and Disease|2022|99

miR‑30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy

|Experimental and Therapeutic Medicine|2017|64

miR-135b-5p promotes gastric cancer progression by targeting CMTM3

|International Journal of Oncology|2017|57

microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases

|Experimental and Therapeutic Medicine|2015|50